Exelixis (EXEL) Restructuring Costs (2010 - 2026)
Exelixis (EXEL) recorded quarterly Restructuring Costs of $684000.0 in Q1 2026, down 96.55% quarter-over-quarter from $19.8 million in Q4 2025, and up 128.0% on a YoY basis from $300000.0 in Q1 2025.
Exelixis (EXEL) Restructuring Costs (2010 - 2026) Analysis & Trends
Exelixis' Restructuring Costs history runs 11 years deep, the most recent figure standing at $684000.0 for Q1 2026.
- In Q1 2026, Restructuring Costs rose 128.0% year-over-year to $684000.0; the TTM figure through Jan 2026 stood at $20.5 million (down 39.19% YoY), while the FY2026 annual figure was $20.5 million, down 39.17% from the prior year.
- Restructuring Costs was $684000.0 for Q1 2026 at Exelixis, down from $19.8 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $32.8 million in Q1 2024 to a low of $100000.0 in Q3 2024.
- Historically, Restructuring Costs has averaged $9.0 million across 3 years, with a median of $579500.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs soared 19716.0% in 2025, then surged 128.0% in 2026.
- A 3-year view of Restructuring Costs shows it stood at $100000.0 in 2024, then jumped by 19716.0% to $19.8 million in 2025, then sank by 96.55% to $684000.0 in 2026.
- The last three Restructuring Costs figures came in at $684000.0 (Q1 2026), $19.8 million (Q4 2025), and $300000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 2, 2026 | 684,000.00 |
| Oct 3, 2025 | 19.82 Mn |
| Jan 3, 2025 | 300,000.00 |
| Sep 27, 2024 | 100,000.00 |
| Jun 28, 2024 | 475,000.00 |
| Mar 29, 2024 | 32.84 Mn |
| Jun 30, 2017 | -60,000.00 |
| Mar 31, 2017 | 28,000.00 |
| Dec 30, 2016 | -228,000.00 |
| Sep 30, 2016 | -244,000.00 |
| Jun 30, 2016 | 1.02 Mn |
| Mar 31, 2016 | 94,000.00 |
| Sep 30, 2015 | 282,000.00 |
| Jun 30, 2015 | 1.29 Mn |
| Mar 31, 2015 | -431,000.00 |
| Dec 31, 2014 | 3.46 Mn |
| Sep 30, 2014 | 3.76 Mn |
| Jun 30, 2014 | 331,000.00 |
| Mar 31, 2014 | 46,000.00 |
| Dec 31, 2013 | 366,000.00 |